|
Jack Lord M.D. joined Humana in 2000 to help develop the company’s consumer-centric business strategy.. In his role as Chief Innovation Officer Dr. Lord is responsible for designing innovative health plan products and leading processes that enable people to navigate the healthcare system and support their health needs.
Dr. Lord created Humana’s Innovation Center a functional blend of research (including consumer research outcomes research and predictive science) product design and consumer experience engineering that is unique to the health benefits industry. His belief in a workplace that encourages exploration discovery and personal growth has led to industry-leading products patent-pending innovations in predictive science and an aggressive entrepreneurship taking the company into global business relationships. In 2006 Dr. Lord began leading Humana's efforts to establish Humana Europe.
With 16 years experience in medical administration he came to Humana from Health Dialog a Boston-based Internet provider of health information to more than 5 million Americans where he served as president and became a leader in e-enabled healthcare. Prior to joining Health Dialog he served as chief operating officer of the American Hospital Association in Washington D.C. executive vice president of Anne Arundel Medical Center in Annapolis MD and executive vice president of Sun Health in Charlotte NC.
A board-certified forensic pathologist Dr. Lord began his medical career in the U.S. Navy where he spent 11 years on active duty most recently as director of the Naval Medical Command’s Quality Assurance Division in the Office of the Surgeon General. He also served as a consultant and surveyor for the Joint Commission on Accreditation of Health Care Organizations. Dr. Lord has published articles on topics ranging from risk management and quality assurance to prostaglandin biosynthesis. In 2002 he received the Karen Coughlin Individual Disease Management Leadership Award from the Disease Management Association of America (DMAA) honoring his contributions to advancements in the care of the millions of U.S. citizens with chronic disease.
His vision leadership and talent for change management have led to appointments to several national boards. As president of the Disease Management Association of America (DMAA) from 2001-2002 Dr. Lord led the organization to restructure its operations significantly increase its membership and revenues and establish branches in Europe Asia and Australia. Also in 2002 he began a three-year term on the National Advisory Council for Healthcare Research and Quality. This prestigious appointment places him among only 21 distinguished health care leaders lending advice to the U.S. Secretary of Health and Human Services.
From 2003-2004 he served as a director at TheraSense a leader in developing personal clinical self-monitoring devices that are simple and comfortable to use and deliver rapid results. There Dr. Lord helped shepherd the company through a period of rapid growth and ultimate acquisition by Abbott Laboratories in early 2004. Also in 2004 Dr. Lord was asked to become a Director of Stericycle an innovative leader in health care infection control and compliance services that is positioning itself to diversity and globalize. | 